Application | Comment | Organism |
---|---|---|
drug development | enzyme NadD is a potentially druggable target suitable for the development of selective inhibitors | Mycobacterium tuberculosis |
medicine | the enzyme is a target for developing antimycobacterial therapies | Mycobacterium tuberculosis |
Cloned (Comment) | Organism |
---|---|
gene nadD, sequence comparisons, recombinant expression of N-terminally His6-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3) | Mycobacterium tuberculosis |
Crystallization (Comment) | Organism |
---|---|
purified recombinant wild-type and W117A mutant enzymes, sitting drop vapour diffusion method at 20°C, microcrystal seeding using hanging drops, mixing of 10 mg/ml protein in 20 mM Tris, pH 7.8, 200 mM NaCl, and 5% v/v glycerol with well solution containing 1.2-1.5 M MgSO4, 0.1 M MES buffer, pH 6.0-6.5, microseeds are added to the drops 1 h later, macrocrystals growth within 3-5 days., X-ray diffraction structure determination and analysis at 2.4 A resolution, molecular replacement | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
D14A | site-directed mutagenesis, almost inactive mutant | Mycobacterium tuberculosis |
H17A | site-directed mutagenesis, almost inactive mutant | Mycobacterium tuberculosis |
H20A | site-directed mutagenesis, almost inactive mutant | Mycobacterium tuberculosis |
K47A | site-directed mutagenesis, the mutant shows a decrease in Km for ATP and a 6fold increase in Km for nicotinate beta-D-ribonucleotide and a nearly abolished enzyme activity | Mycobacterium tuberculosis |
L164A | site-directed mutagenesis, the L164A mutant elutes as both a monomer and a dimer during purification, the mutant shows 40fold reduced activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
L164Q | site-directed mutagenesis, the L164Q mutant elutes as both a monomer and a dimer during purification, almost inactive mutant | Mycobacterium tuberculosis |
P44A | site-directed mutagenesis, the mutant shows a decrease in Km for ATP | Mycobacterium tuberculosis |
Q46A | site-directed mutagenesis | Mycobacterium tuberculosis |
T12A | site-directed mutagenesis, the T12A mutant elutes as a dimer and as an aggregated protein during purification, the mutant shows highly reduced activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
T86A | site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
W117A | site-directed mutagenesis, the mutant shows a 10fold higher expression level compared to the wild-type enzyme in Escherichia coli, three-dimensional structure determination and analysis, the mutant shows highly reduced activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
W117F | site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
W45A | site-directed mutagenesis | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | MIC80 values of 0.02-0.1 mM and above. The compounds show no inhibition of the human enzyme | Mycobacterium tuberculosis | |
2-(2,4-dimethylphenyl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(2,4-dimethylphenyl)-N-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(2-chlorophenyl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(4-bromophenyl)-N-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(furan-2-yl)-N-[3-(3,4,5,6-tetrahydropyridin-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(furan-2-yl)-N-[3-methoxy-4-(morpholin-4-ylsulfonyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(furan-2-yl)-N-[3-methyl-4-(morpholin-4-ylsulfonyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-(pyridin-4-yl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
2-phenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]benzamide | - |
Mycobacterium tuberculosis | |
4-[ethyl(phenyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | - |
Mycobacterium tuberculosis | |
additional information | inhibitory profiling of partially active mutants and wild-type enzyme MtNadD using small molecule inhibitors, overview. Substrate inhibition in an ordered bi-reactant system | Mycobacterium tuberculosis | |
N-[3-(3,4-dihydro-2H-pyrrol-5-ylsulfamoyl)phenyl]-2-(furan-2-yl)quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
N-[3-[1-(6-chloro-4-phenylquinazolin-2-yl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl]methanesulfonamide | - |
Mycobacterium tuberculosis | |
N-[4-(3,4-dihydro-2H-pyrrol-5-ylsulfamoyl)phenyl]-2-(furan-2-yl)quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
N-[4-(4-iodophenyl)-1,3-thiazol-2-yl]-3-[(phenylsulfonyl)amino]benzamide | - |
Mycobacterium tuberculosis | |
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-3-[(phenylsulfonyl)amino]benzamide | - |
Mycobacterium tuberculosis | |
N-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]-3-methylphenyl]-2-(4-methoxyphenyl)quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
N-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]-3-methylphenyl]-2-(4-methylphenyl)quinoline-4-carboxamide | - |
Mycobacterium tuberculosis | |
S-(4-bromo-8-chloronaphthalen-1-yl) [4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamothioate | - |
Mycobacterium tuberculosis |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | steady-state kinetic analysis, sequential kinetic mechanism, bisubstrate enzyme kinetics, overview | Mycobacterium tuberculosis | |
0.006 | - |
ATP | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
0.011 | - |
ATP | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis | |
0.011 | - |
ATP | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
0.017 | - |
ATP | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
0.023 | - |
ATP | pH 7.5, 37°C, recombinant mutant W117F | Mycobacterium tuberculosis | |
0.033 | - |
ATP | pH 7.5, 37°C, recombinant mutant Q46A | Mycobacterium tuberculosis | |
0.041 | - |
ATP | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | |
0.042 | - |
ATP | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
0.17 | - |
ATP | pH 7.5, 37°C, recombinant mutant L164A | Mycobacterium tuberculosis | |
0.19 | - |
ATP | pH 7.5, 37°C, recombinant mutant L164Q | Mycobacterium tuberculosis | |
0.33 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant Q46A | Mycobacterium tuberculosis | |
0.43 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164Q | Mycobacterium tuberculosis | |
0.48 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | |
0.52 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164A | Mycobacterium tuberculosis | |
0.53 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
0.84 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
0.98 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
1.13 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117F | Mycobacterium tuberculosis | |
2.67 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117A | Mycobacterium tuberculosis | |
2.7 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
2.8 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Mycobacterium tuberculosis |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
27000 | - |
2 * 27000, SDS-PAGE | Mycobacterium tuberculosis |
54000 | - |
about, gel filtration | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + nicotinate beta-D-ribonucleotide | Mycobacterium tuberculosis | - |
diphosphate + deamido-NAD+ | - |
? | |
ATP + nicotinate beta-D-ribonucleotide | Mycobacterium tuberculosis H37Rv | - |
diphosphate + deamido-NAD+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WJJ5 | gene nadD | - |
Mycobacterium tuberculosis H37Rv | P9WJJ5 | gene nadD | - |
Purification (Comment) | Organism |
---|---|
recombinant N-terminally His6-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, tag cleavage from wild-type enzyme and W117A mutant enzyme through Ulp1 protease or TEV protease, and anion exchange chromatography and dialysis | Mycobacterium tuberculosis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + nicotinate beta-D-ribonucleotide | - |
Mycobacterium tuberculosis | diphosphate + deamido-NAD+ | - |
? | |
ATP + nicotinate beta-D-ribonucleotide | - |
Mycobacterium tuberculosis H37Rv | diphosphate + deamido-NAD+ | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | 2 * 27000, SDS-PAGE | Mycobacterium tuberculosis |
More | three-dimensional structure enzyme structure determination and analysis, crystal structure analysis | Mycobacterium tuberculosis |
Synonyms | Comment | Organism |
---|---|---|
nadD | - |
Mycobacterium tuberculosis |
nicotinate mononucleotide adenylyltransferase | - |
Mycobacterium tuberculosis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Mycobacterium tuberculosis |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.002 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117A | Mycobacterium tuberculosis | |
0.015 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164Q | Mycobacterium tuberculosis | |
0.02 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
0.03 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117F | Mycobacterium tuberculosis | |
0.13 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164A | Mycobacterium tuberculosis | |
0.2 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis | |
0.22 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
0.36 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
0.37 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
4.7 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant Q46A | Mycobacterium tuberculosis | |
5.5 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | binding site structure, overview | Mycobacterium tuberculosis |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | inhibition kinetics, overview | Mycobacterium tuberculosis | |
0.024 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
0.03 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant W117A | Mycobacterium tuberculosis | |
0.035 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | |
0.037 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
0.056 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
0.094 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
0.114 | - |
2-(2,4-dimethylphenyl)-N-(4-([(5-methyl-3-isoxazolyl)amino]sulfonyl)phenyl)-4-quinolinecarboxamide | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.017 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(furan-2-yl)-N-[3-(3,4,5,6-tetrahydropyridin-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | |
0.024 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]benzamide | |
0.024 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | S-(4-bromo-8-chloronaphthalen-1-yl) [4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamothioate | |
0.033 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(2-chlorophenyl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | |
0.035 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(2,4-dimethylphenyl)-N-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]quinoline-4-carboxamide | |
0.036 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(2,4-dimethylphenyl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | |
0.043 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-phenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | |
0.046 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[4-(3,4-dihydro-2H-pyrrol-5-ylsulfamoyl)phenyl]-2-(furan-2-yl)quinoline-4-carboxamide | |
0.049 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[3-(3,4-dihydro-2H-pyrrol-5-ylsulfamoyl)phenyl]-2-(furan-2-yl)quinoline-4-carboxamide | |
0.049 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(4-bromophenyl)-N-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl]quinoline-4-carboxamide | |
0.051 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(furan-2-yl)-N-[3-methyl-4-(morpholin-4-ylsulfonyl)phenyl]quinoline-4-carboxamide | |
0.056 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(pyridin-4-yl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]quinoline-4-carboxamide | |
0.074 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 2-(furan-2-yl)-N-[3-methoxy-4-(morpholin-4-ylsulfonyl)phenyl]quinoline-4-carboxamide | |
0.096 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | 4-[ethyl(phenyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | |
0.116 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-3-[(phenylsulfonyl)amino]benzamide | |
0.13 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]-3-methylphenyl]-2-(4-methylphenyl)quinoline-4-carboxamide | |
0.13 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]-3-methylphenyl]-2-(4-methoxyphenyl)quinoline-4-carboxamide | |
0.13 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[3-[1-(6-chloro-4-phenylquinazolin-2-yl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl]methanesulfonamide | |
0.18 | - |
pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | N-[4-(4-iodophenyl)-1,3-thiazol-2-yl]-3-[(phenylsulfonyl)amino]benzamide |
General Information | Comment | Organism |
---|---|---|
additional information | the enzyme has a unique 310 helix that locks the active site in an over-closed conformation. This renders the enzyme inactive as it is topologically incompatible with substrate binding and catalysis. The enzyme contains the signature motifs GXFXPX(H/T)XXH and SXTXXR mainly implicated in ATP binding. Mechanistic modelling, overview | Mycobacterium tuberculosis |
physiological function | nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD+ cofactor | Mycobacterium tuberculosis |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0008 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117A | Mycobacterium tuberculosis | |
0.007 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
0.008 | - |
ATP | pH 7.5, 37°C, recombinant mutant L164Q | Mycobacterium tuberculosis | |
0.03 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W117F | Mycobacterium tuberculosis | |
0.04 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164Q | Mycobacterium tuberculosis | |
0.07 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis | |
0.08 | - |
ATP | pH 7.5, 37°C, recombinant mutant L164A | Mycobacterium tuberculosis | |
0.4 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
0.4 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
0.4 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
1.3 | - |
ATP | pH 7.5, 37°C, recombinant mutant W117F | Mycobacterium tuberculosis | |
2.5 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant L164A | Mycobacterium tuberculosis | |
3 | - |
ATP | pH 7.5, 37°C, recombinant mutant K47A | Mycobacterium tuberculosis | |
5 | - |
ATP | pH 7.5, 37°C, recombinant mutant T12A | Mycobacterium tuberculosis | |
12 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | |
14 | - |
nicotinate beta-D-ribonucleotide | pH 7.5, 37°C, recombinant mutant Q46A | Mycobacterium tuberculosis | |
18 | - |
ATP | pH 7.5, 37°C, recombinant mutant T86A | Mycobacterium tuberculosis | |
21 | - |
ATP | pH 7.5, 37°C, recombinant mutant P44A | Mycobacterium tuberculosis | |
34 | - |
ATP | pH 7.5, 37°C, recombinant mutant W45A | Mycobacterium tuberculosis | |
134 | - |
ATP | pH 7.5, 37°C, recombinant wild-type enzyme | Mycobacterium tuberculosis | |
142 | - |
ATP | pH 7.5, 37°C, recombinant mutant Q46A | Mycobacterium tuberculosis |